Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Viridian Therapeutics Inc
VRDN
Healthcare
Biotechnology
Viridian Therapeutics, Inc. is a biopharmaceutical company focused on engineering and developing potential medicines for patients with serious and rare diseases. The Company is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The Company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and...
efficacy of VRDN-001 in patients with active and chronic TED. It is focused on advancing VRDN-001 as a potential intravenous therapy followed by VRDN-003 as a potential subcutaneous therapy for the treatment of TED. Its advanced program, VRDN-001, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED. In addition to its TED portfolio, the Company is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:VRDN)
New Post
View:
Posts & Comments
Threaded Posts
(280)
•••
whytestocks
X
Post by
whytestocks
on Sep 23, 2024 3:30am
Trading (VRDN) With Integrated Risk Controls
NEWS: $VRDN Trading (VRDN) With Integrated Risk Controls2024-09-23 03:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Sep 13, 2024 11:31am
VRDN Price Target Alert: $44.00. Issued by RBC Capital
News; $VRDN VRDN Price Target Alert: $44.00. Issued by RBC Capital2024-09-13 09:00:07 ET Gregory Renza from RBC Capital issued a price target of $44.00 for VRDN on 2024-09-13 07:52:00. The adjusted
...more
Options Trading for Retiring: Cash flow in Your Golden years
posted Dec 07, 2024 9:00am by
Bank of Montreal
-
|
To maintain a plan for retiring comfortably, several key strategies must be kept in mind so retirees can continue generating income. These can include covered calls, cash secured puts, selling put-spreads, and buy-write strategies. BMO’s enhanced InvestorLine platform has industry-leading tools and capabilities specifically designed to empower options traders with access to a wealth of educational content. ...read more
(280)
•••
whytestocks
X
Post by
whytestocks
on Sep 12, 2024 2:02pm
Trend Tracker for (VRDN)
News; $VRDN Trend Tracker for (VRDN)2024-09-12 08:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and
...more
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 01, 2024 5:19pm
Viridian Therapeutics: Advancing Innovative Therapies for Th
https://beyondspx.com/2024/08/01/viridian-therapeutics-advancing-innovative-therapies-for-thyroid-eye-disease-and-autoimmune-disorders/
(280)
•••
whytestocks
X
Post by
whytestocks
on Jun 11, 2024 3:00pm
Outperform Recommendation Issued On VRDN By RBC Capital
Breaking News: $VRDN Outperform Recommendation Issued On VRDN By RBC Capital2024-06-11 14:30:05 ET RBC Capital analyst issues OUTPERFORM recommendation for VRDN on June 11, 2024 12:47PM ET. The
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?